Compare · BDMD vs SYK
BDMD vs SYK
Side-by-side comparison of Baird Medical Investment Holdings Ltd (BDMD) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BDMD and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK is the larger of the two at $129.30B, about 28488.7x BDMD ($4.5M).
- SYK has been more active in the news (10 items in the past 4 weeks vs 4 for BDMD).
- SYK has more recent analyst coverage (25 ratings vs 0 for BDMD).
- Company
- Baird Medical Investment Holdings Ltd
- Stryker Corporation
- Price
- -
- -
- Market cap
- $4.5M
- $129.30B
- 1M return
- -
- +22.08%
- 1Y return
- -
- -5.00%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 4
- 10
- Recent ratings
- 0
- 25
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest BDMD
- Baird Medical Issues Statement Regarding Recent Share Price Volatility
- Baird Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China
- Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology
- Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026
- SEC Form SCHEDULE 13G filed by Baird Medical Investment Holdings Ltd
- SEC Form 6-K filed by Baird Medical Investment Holdings Ltd
- SEC Form 6-K filed by Baird Medical Investment Holdings Ltd
- SEC Form 424B5 filed by Baird Medical Investment Holdings Ltd
- Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Latest SYK
- SEC Form S-3ASR filed by Stryker Corporation
- SEC Form IRANNOTICE filed by Stryker Corporation
- SEC Form 10-Q filed by Stryker Corporation
- Stryker downgraded by Canaccord Genuity with a new price target
- SEC Form 8-K filed by Stryker Corporation
- Stryker reports third quarter 2026 operating results
- Stryker to participate in the 2026 Jefferies Global Healthcare Conference
- Stryker completes acquisition of ZuriMED to enhance its shoulder offering
- Stryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal
- Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery